COVID-19-associated ischaemic stroke due to underlying carotid artery thrombosis in a healthy young woman. Issue 8 (3rd August 2021)

• Record Type: Journal Article
• Authors: Lau, Kelly; White-Gittens, Irwin; Schor, Jonathan; Guerges, Mina
• Is Part Of: BMJ case reports. Volume 14:Issue 8(2021)
• Publication Date: 2021-08-03
• Subjects: COVID-19 -- vascular surgery -- haematology (drugs and medicines) -- stroke -- haematology (incl blood transfusion); Medicine -- Case studies -- Periodicals; 610.5
• DOI: 10.1136/bcr-2021-244396
• Languages: English
• ISSNs: 1757-790X

Abstract

Abstract : SARS-CoV-2 has proven its versatility in host presentations; one such presentation is a hypercoagulable state causing large-vessel thrombosis. We report a case on a previously asymptomatic COVID-19-positive patient presenting with an acute ischaemic stroke and an incidental left internal carotid artery thrombus. The patient's medical, social and family history and hypercoagulability screening excluded any other explanation for the left carotid thrombus or stroke, except for testing positive for the COVID-19. This case explores the known hypercoagulable state associated with COVID-19 and the effect of the virus on the host's immune response. It also questions whether administration of recombinant tissue plasminogen activator (t-PA), according to the American Heart Association guidelines, following a negative head CT for haemorrhagic stroke is safe without prior extended imaging in this patient population. We recommend, in addition to obtaining a non-contrast CT scan of the brain, a CT angiogram or carotid duplex of the neck be obtained routinely in patients with COVID-19 exhibiting stroke symptoms before t-PA administration as the effects may be detrimental. This recommendation will likely prevent fragmentation and embolisation of an undetected carotid thrombus.